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Abstract
Background: Individual-based modeling is a growing technique in the HIV transmission and prevention literature, but
insufficient attention has been paid to formally evaluate the quality of reporting in this field. We present reporting
recommendations for individual-based models for HIV treatment and prevention, assess the quality of reporting in the
existing literature, and comment on the contribution of this model type to HIV policy and prediction.
Methods: We developed reporting recommendations for individual-based HIV transmission mathematical models,
and through a systematic search, used them to evaluate the reporting in the existing literature. We identified papers
that  employed  individual-based  simulation  models  and  were  published  in  English  prior  to  December  31,  2012.
Articles were included if the models they employed simulated and tracked individuals, simulated HIV transmission
between individuals in a particular population, and considered a particular treatment or prevention intervention. The
papers were assessed with the reporting recommendations.
Findings:  Of  214  full  text  articles  examined,  32  were  included  in  the  evaluation,  representing  20  independent
individual-based  HIV  treatment  and  prevention  mathematical  models.  Manuscripts  universally  reported  the
objectives, context, and modeling conclusions in the context of the modeling assumptions and the model’s predictive
capabilities, but the reporting of individual-based modeling methods, parameterization and calibration was variable.
Six papers discussed the time step used and one discussed efforts to maintain internal validity in coding.
Conclusion: Individual-based models represent detailed HIV transmission processes with the potential to contribute
to inference and policy making for many different regions and populations. The rigor in reporting of assumptions,
methods, and calibration of individual-based models focused on HIV transmission and prevention varies greatly.
Higher  standards  for  reporting  of  statistically  rigorous  calibration  and  model  assumption  testing  need  to  be
implemented to increase confidence in existing and future modeling results.
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Introduction
HIV  transmission  is  influenced  by  numerous  interactions
between  the  biology  of  the  virus  and  the  behavior  of
individuals.  The  dynamics  of  transmission,  treatment,  and
prevention  are  increasingly  being  represented  by  infectious
disease mathematical models, which are accepted in the HIV
literature as powerful predictive tools that motivate policy and
inform  clinical  trial  design  [1].  Given  the  complexities  of  HIV
transmission,  models  that  represent  individual-level  behavior
and  partnering  can  be  especially  valuable.  Individual-based
simulations  increase  flexibility  by  allowing  for  heterogeneous
individuals,  interactions  between  individuals,  correspondence
to real life data, and a representation of the environment with
which  individuals  interact  [2,3].  This  model  type  also  allows
individuals to have rationality in their actions (as opposed to
completely  random  behavior)  and  simulates  learning  at
individual and population levels [2]. However, individual-based
models are difficult to parametrize, analyze, and generalize due
to  their  complexity,  leaving  researchers  to  balance  the
advantages  and  disadvantages  of  this  model  type  in  the
context of the problem of interest. As researchers begin large
scale  community  randomized  trials  to  assess  the  costs  and
benefits of HIV treatment and prevention interventions, there is
a need for sophisticated and validated individual-level models
to inform these studies’ designs.
The need for more consistent evaluation and comparison of
mathematical models in the literature is a common theme in
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model users have noted that there has been a decline in the
reporting  standards  in  the  literature,  and  this  may  be
contributing  to  its  lack  of  use  in  many  fields  [4,7].  Previous
reviews  have  aimed  to  provide  the  proper  guidelines  and
documentation for mathematical models and simulations in the
literature  [5,6,8-11],  but  none  have  focused  on  the  specific
issues  related  to  reporting  of  individual-based  models  in  the
context of HIV transmission and prevention.
In this paper, we describe the scope and quality of reporting
of  individual-based  models  in  the  HIV  transmission  and
prevention literature. We first provide recommended reporting
guidelines  for  individual-based  mathematical  models  by
tailoring previous mathematical modeling reporting guidelines
to the individual-based model approach. We then apply these
guidelines  to  existing  HIV  transmission  and  prevention
individual-based  models  (found  through  a  systematic  search
strategy) to assess the quality of reporting for this model type.
We hope these guidelines will be a starting point for discussion
with modelers to form standardized reporting guidelines for the
united goal of improving the quality of the individual-based HIV
modeling  literature,  and  increasing  their  use  among  policy
making consumers.
Methods
Reporting Recommendations
The  following  recommended  reporting  guidelines  were
constructed  by  expanding  upon  those  presented  in  previous
modeling  reviews  and  from  the  experience  of  the  authors
(Table 1). The guidelines highlight the necessary components
of  general  mathematical  model  reporting  and  the  specific
issues related to individual-based model reporting. We present
each  recommended  guideline  and  provide  the  rationale  for
including  the  item  with  reference  to  the  literature.  Our
guidelines do not rely on a specific reporting structure or article
layout,  as  individual-based  models  are  published  in  a  wide
variety  of  journal  types.  Instead  our  recommendations  are
organized  into  six  sections  according  to  different  aspects  of
model development and presentation: 1) rationale, scope, and
objective;  2)  structure  and  features;  3)  parameters;  4)
assessment  and  validation;  5)  presentation  of  results  and
conclusions; 6) authorship and funding (see Table 1).
Item 1: Title and Abstract – Identify in the title or abstract
that  the  analysis  depends  on  an  individual-based
mathematical  model.    Whether  the  structure  of  a
mathematical  model  can  be  identified  depends  on  how  it  is
indexed in the literature, which relies on an informative title [12]
and  abstract.  By  indicating  in  the  title  or  abstract  that  the
analysis  involves  an  individual-based  mathematical  model,
authors  alert  readers  to  be  aware  of  particular  assumptions,
structure, and details in the body of the paper.
Item 2: Objective – State the objectives of the analysis
with  specific  reference  to  the  population(s),
intervention(s), and time period(s) of interest.  Objectives
should address the questions that the mathematical modeling
exercise  aims  to  answer,  and  reflect  the  efficacy,  feasibility,
and/or affordability of a particular HIV treatment or prevention
Table 1. Recommended reporting guidelines for individual-
based models of HIV transmission and prevention*.
Topic # Item
RATIONALE, SCOPE, AND OBJECTIVES
Title and
Abstract
1
Identify in the title or abstract that the analysis depends on
an individual-based mathematical model.
Objective 2
State the objectives of the analysis with specific reference to
the population(s), intervention(s), and time period(s) of
interest.
Context 3
Justify the exploration of the policy question in the context of
previous trials, cohorts, and modeling analyses for the time
period(s) of interest.
Model
Justification
4
Explain the need for an individual-based model in the
context of the objectives by referencing necessary
model features.
STRUCTURE AND FEATURES
Structure 5
Describe the model’s structure in both words and figures and
describe how it affords the ability to explore the question(s)
of interest.
Assumptions 6
State the assumptions implicit in the model structure and
justify with knowledge and data from the population of
interest.
Validity of
Sexual
Behavior
7
Justify the validity of the necessary behavior accounted for in
the model.
Validity of
Biology
8
Justify the validity of the necessary biology accounted for in
the model.
PARAMETERS
Parameters 9
List fixed parameters and calibrated parameters with ranges
justified by the literature.
Time step 10
State and justify the length of the time step used to
advance model dynamics, if applicable.
Heterogeneity 11
Discuss how biological and behavioral heterogeneity is
implemented in the model structure and whether this
implementation allows for flexibility and specificity.
Interaction 12
Describe the parameters used to implement individual
interaction in the model and justify the data used to
parameterize these parameters.
ASSESSMENT AND VALIDATION
Calibration 13
If the objective of the analysis is to describe or predict
dynamics in a particular population of interest, describe
the process used to calibrate the model dynamics to
existing data including the statistical procedure, the
types of outcome measures used, and the quality of the
data used.
Sensitivity
Analyses
14
Summarize the results of sensitivity analyses on the main
model parameters, discuss whether the results support the
robustness of findings, and describe future work needed.
Assumption
Sensitivity
15
Discuss how the behavior and inference of the model
changes when particular assumptions (e.g. alternative
mixing patterns, different levels of heterogeneity for
behavior and biology) are altered or deleted.
Stochastic
Sensitivity
16
Summarize the impact of stochasticity on the model
runs and justify through random seed variation and
sample size variation.
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paper’s methods and clarify the paper’s goals. The specificity
of  the  objectives,  especially  with  respect  to  the  population,
intervention,  and  time  period  of  interest,  justifies  the  model
structure  and  indicates  the  data  needs  of  the  analysis.  The
information  on  setting  and  population  will  be  essential  for
readers to assess the applicability and generalizability of the
mathematical modeling results [12].
Item  3:  Context  –  Justify  the  exploration  of  the  policy
question  in  the  context  of  previous  trials,  cohorts,  and
modeling  analyses  for  the  time  period(s)  of
interest.  Authors should explain how their analysis adds to the
existing  literature  by  noting  previous  trials,  studies,  and
modeling exercises that address similar questions. The political
and  social  context  of  the  tested  intervention  should  also  be
discussed, to inform the readers of the potential consequences
of this exploration [5]. The need for a new model should be
justified if there is expansion on an existing model or model
structure.
Item  4:  Model  Justification  –  Explain  the  need  for  an
individual-based mathematical model in the context of the
objectives by referencing necessary model features (e.g. a
need  for  heterogeneity  of  individual  behavior  and/or
Table 1 (continued).
Topic # Item
Internal Validity 17
Describe the validity of the model programming by
discussing how model bugs and program issues were
checked and if modifications to model implementation
were explored.
PRESENTATION OF RESULTS AND DISCUSSION
Data Quality 18
Describe the quantity and quality of the data used to inform
parameters for the population(s) of interest.
Data
Conversion
19
Discuss issues related to the conversion of data to fit
the time step used.
Results 20
Present key modeling results with uncertainty estimates and
indicate how many parameter sets were run for each
analysis.
Limitations and
Strengths
21
Provide the key limitations and strengths of the modeling
study.
Reproducibility 22
Discuss whether the model is able to reproduce the
behavior of other populations or interventions of interest.
Discussion 23
Interpret the modeling analysis within realistic bounds, with
reference to previous modeling studies, a discussion about
the generalizability of the modeling results, and implications
for future studies or models.
AUTHORSHIP AND
FUNDING
               
Authorship and
Funding
24
List sources of funding and describe each author’s
contribution to the modeling framework and
conceptualization.
*. Bolded guidelines are specific to individual-based models of HIV transmission
and  prevention.  Non-bolded  guidelines  are  adaptable  across  different  types  of
models.
doi: 10.1371/journal.pone.0075624.t001
biology,  and/or  the  explicit  modeling  of  the  interaction
between individuals)
The  reasoning  for  the  use  of  an  individual-based  model
should be clarified early in the paper structure. Because our
reporting guidelines are specific to mathematical analyses with
a  specific  intervention,  the  need  to  justify  a  model’s  design
becomes necessary. Authors should emphasize the need for
an individual-based model design by discussing the necessity
of heterogeneity as well as explicit interaction of individuals in
the context of the objectives, or other model necessary model
features  they  have  incorporated  that  are  essential  to  their
analysis [8,10,13]. .
Item  5:  Structure  –  Describe  the  model’s  structure  in
both  words  and  figures  and  describe  how  it  affords  the
ability to explore the question(s) of interest.  By indicating
the model structure in both words and figures, the authors are
able  to  communicate  effectively  with  the  readers  about  the
capability of the model structure and the validity of the model’s
assumptions [8]. Figures are important for those unfamiliar with
mathematical modeling, as they give a visual representation of
what is happening inside of the model structure. Avoiding the
“black-box” phenomenon will allow readers to better judge the
quality  of  mathematical  models  in  the  literature  and  the
subsequent results that arise from them [14]. Without a clear
understanding of the structure of a given mathematical model,
readers  will  have  a  difficult  time  piecing  together  which
analyses and explorations are feasible.
Item 6: Assumptions – State the assumptions implicit in
the model structure and justify with knowledge and data
from the population of interest.  The generalizability of the
conclusions drawn from the model analysis are dictated by the
model’s  assumptions  [13].  Data  used  to  justify  assumptions
should be included, so readers are aware of all limitations of
the modeling approach. Simplifying assumptions related to the
interaction of individuals in the population and the progression
of HIV should be highlighted, as these have a direct impact on
the authors’ ability to make accurate inferences.
Item 7: Validity of Sexual Behavior – Justify the validity
of  the  necessary  behavior  accounted  for  in  the
model.  Many aspects of sexual behavior are important to the
transmission  and  prevention  of  HIV  in  a  population,  and  the
level of detail inherent in individual-based models with respect
to  sexual  behavior  is  much  higher  than  any  other  type  of
modeling [15]. Authors should discuss all relevant behavioral
processes  including,  but  not  limited  to:  relationship  types,
relationship durations, directionality in men who have sex with
men (MSM) partnerships, number of sex acts per time step,
presence  or  absence  of  risk  groups,  mixing  pattern,
mechanism of acquisition of partnerships, age of sexual debut,
change  in  sexual  behavior  with  aging  or  time,  presence  or
absence of migration, and the presence or absence of testing
and the treatment cascade. The elements of sexual behavior
included  in  the  model  will  depend  on  the  analysis  and
population of interest and should be justified using data and
information from the population of interest [8]. Authors should
acknowledge  poorly  understood  behaviors  and  limitations  in
data used to inform parameters.
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necessary biology accounted for in the model.  The level of
biological  detail  that  an  individual-based  model  should
represent  is  dependent  upon  the  aims  of  the  analysis  of
interest.  Many  elements  of  individual-  and  community-level
biology  are  important  to  the  transmission  and  prevention  of
HIV,  for  example:  the  inclusion  or  exclusion  of  sexually
transmitted infection, the tracking of virological markers (CD4/
HVL), multiple HIV disease stages with differing transmission
probabilities,  impact  of  circumcision  status  on  HIV
transmission, presence or absence of opportunistic infections,
the  impact  of  treatment  on  health  and  future  transmission
events, and the presence or absence of resistance mutations.
By  describing  the  elements  incorporated  in  the  model,  the
readers  are  able  to  determine  which  aspects  of  HIV
transmission and prevention can be assessed.
Item 9: Parameters - List fixed parameters and calibrated
parameters with ranges justified by the literature.  When
individual-based  models  begin  to  represent  sexual  behavior
and  biology,  the  number  of  parameters  needed  to  populate
them grows dramatically [10]. By listing the main parameters
examined in the analyses of interest, the readers are able to
understand  the  necessary  sources  of  the  data.  Further,
including uncertainty ranges establishes the need for attaining
parameter values through a fitting or calibration procedure (see
Item 13) when data is not available from the literature. Where
parameter values cannot be based on the literature or are not
calibrated, data from similar populations or assumptions made
about the population of interest should be provided [7,8].
Item 10: Time Step - State and justify the length of the
time  step  used  to  advance  model  dynamics,  if
applicable.    The  time  step  in  an  individual-based  model  is
determined  by  the  level  of  detail  desired  and  computational
limitations [13]. A short time step will provide greater detail on
sexual behavior and biology, but will cause longer run times.
Explicitly  stating  the  time  step,  where  appropriate,  will  make
clear which processes the model describes well and makes the
necessary  data  conversions  for  parameters  transparent  (see
Item 19).
Item  11:  Heterogeneity  -  Discuss  how  biological  and
behavioral  heterogeneity  is  implemented  in  the  model
structure  and  whether  this  implementation  allows  for
flexibility and specificity.  One of the main strengths of the
individual-based  model  structure  is  the  ability  to  represent
heterogeneity  in  behavior  and  biology  [3]  and,  as  such,
methods  used  to  implement  this  heterogeneity  need  to  be
detailed.  Specific  details  on  the  discrete  categories  or
continuous  distributions  used  should  be  reported  in  the
manuscript  or  supplementary  material.  Emphasizing  the
particular  elements  of  behavior  and  biology  that  vary  across
individuals allows readers to understand how accurately these
processes  reflect  reality  and  highlights  strengths  of  the
modeling exercise.
Item 12: Interaction - Describe the parameters used to
implement individual interaction in the model and justify
the  data  used  to  parameterize  these  parameters.    HIV
transmission that occurs within a particular partnership needs
to  be  modeled  accurately.  Partnership  formation  and
dissolution, the number of sexual acts in each partnership, the
directionality  of  MSM  partnerships,  and  the  types  of
partnerships should be described in detail. By putting emphasis
on  the  interaction  between  individuals  in  an  individual-based
model,  authors  will  clearly  describe  the  level  of  interaction
between  agents  and  consequently  justify  the  need  for  this
interaction.
Item 13: Calibration - If the objective of the analysis is to
describe or predict dynamics in a particular population of
interest, describe the process used to calibrate the model
dynamics  to  existing  data  including  the  statistical
procedure, the types of outcome measures used, and the
quality of the data used
The  process  through  which  the  model’s  predictions,  with
regard  to  particular  outcomes,  are  matched  to  data  in  the
population of interest is called calibration [9]. There are many
methods through which calibration can be statistically rigorous
[5,9] and other methods through which it can be performed less
rigorously.  Calibration  may  be  the  most  important  piece  of
reported  information  for  inferring  a  model’s  ability  to  make
accurate  inferences  about  a  particular  population;  therefore,
details  on  the  algorithms  used  and  the  outcomes  calibrated
should  be  provided.  Although  a  model  only  needs  to  be
calibrated once to reflect dynamics in a particular population,
the  calibration  process  should  be  repeated  if  the  population,
time period, or outcome of interest change. Models that have
previously  been  calibrated  should  cite  relevant  previous
manuscripts, and briefly describe the process. Authors should
also make note of any effort to avoid over-fitting the model to
data [16].
Item 14: Sensitivity Analyses - Summarize the results of
sensitivity  analyses  on  the  main  model  parameters,
discuss  whether  the  results  support  the  robustness  of
findings, and describe future work needed
As with any statistical analysis, it is essential to understand
the sensitivity of the results to perturbations in parameters that
are  directly  related  to  the  intervention  of  interest  [7].  For
example, a model investigating how vaccine coverage impacts
HIV  incidence  should  vary  vaccine  coverage  and  efficacy  to
understand how model structure and parameterization impact
the results. Sensitivity analyses may identify potential areas of
model  improvement  and  these  discoveries  should  be  noted.
Less  important  results  can  be  reported  in  supplemental
material or an appendix.
Item  15:  Assumption  Sensitivity  -  Discuss  how  the
behavior  and  inference  of  the  model  changes  when
particular  assumptions  (e.g.  alternative  mixing  patterns,
different levels of heterogeneity for behavior and biology)
are altered or deleted
After  describing  the  assumptions  inherent  in  the  model
structure  (see  Item  6),  the  authors  should  discuss  how  the
model’s  behavior  was  dependent  on  these  assumptions  [8].
Assumption sensitivity analyses will reinforce the necessity of
individual-based model structure and highlight which aspects of
the intervention other model types would not capture. This type
of  sensitivity  analysis  will  allow  the  authors  to  explore  the
generalizability  of  the  model  results  to  situations  where  the
assumptions are violated [7,9]. Modelers will usually alter the
Reporting of HIV Individual-Based Models
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but altering other assumptions will improve the plausibility of
the  model  results.  Assumption  sensitivity  analyses  can  be
performed in many different ways, one of which compares the
results  from  the  individual-based  model  to  a  deterministic
model with simplified dynamics.
Item 16: Stochastic Sensitivity - Summarize the impact
of  stochasticity  on  the  model  runs  and  justify  through
random  seed  variation  and  sample  size
variation.    Microsimulation  models  are  often  stochastic,
meaning  there  is  a  certain  level  of  randomness  inherent  to
each model run [9,13]. Stochasticity can affect large simulation
models in different ways, depending on which processes rely
on random number generation. Authors should describe how
stochasticity affects model results and what the authors have
done to understand these effects, including increasing sample
size or seeding the population differently [7].
Item  17:  Internal  Validity  -  Describe  the  validity  of  the
model programming by discussing how model bugs and
program  issues  were  checked  and  if  modifications  to
model implementation were explored.  The internal validity
of the model should be discussed, highlighting the steps taken
to  debug  the  model  program  and  check  the  validity  of  the
model structure [7,10]. This information should be placed in an
appendix or supplemental material. Publications on previously
published  models  should  refer  back  to  the  methods  of  the
original  manuscript,  but  should  not  necessarily  repeat  the
internal validity checks, unless the program code was changed.
It is good practice to have two individuals program the model
independently and compare the implementation to avoid bugs
[7],  though  we  acknowledge  limited  personnel  or  resources
may make this infeasible. Model flowcharts, debugging runs,
and  other  measures  can  also  prevent  bugs  in  the
implementation of the code.
Item 18: Data Quality - Describe the quantity and quality
of the data used to inform parameters for the population(s)
of interest.  As mentioned in Item 9, the number of parameters
needed to populate an individual-based model is large, and it
may  be  difficult  to  find  data  for  the  parameters  needed.  A
discussion of the data quality for the population and region of
interest  will  allow  readers  to  understand  the  limitations  to
modeling  in  this  population  [10]  and  may  encourage  public
health  researchers  and  social  scientists  to  collect  additional
relevant data.
Item 19: Data Conversion - Discuss issues related to the
conversion of data to fit the time step used.  The time step
used is not often motivated by the data available, but rather by
the goal of realism set by the authors. Data often has to be
converted to the proper time step (e.g. number of sexual acts
per  partnership  per  time  step).  Any  additional  assumptions
required for conversion should be discussed.
Item  20:  Results  -  Present  key  modeling  results  with
uncertainty  estimates  and  indicate  how  many  parameter
sets were run for each analysis.  Authors should report their
results  with  uncertainty  estimates.  Particularly  for  individual-
based  models,  authors  should  disclose  the  number  of
parameter  sets  used  or  runs  averaged  to  get  the  results.
Discussing uncertainty in results will help the authors anchor
their conclusions (see Item 23) and give the readers a better
understanding of the capabilities of the model.
Item  21:  Limitations  and  Strengths  -  Provide  the  key
limitations  and  strengths  of  the  modeling  study.    The
strengths  and  limitations  of  the  methods  used  should  be
highlighted [12]. The limitations of an individual-based model
are  often  dependent  on  the  assumptions  made,  the
computational power available, and the data used to inform the
parameters.  Detailed  models  of  sexual  behavior  and
transmission should emphasize the strengths of these details,
while  recognizing  the  potential  weaknesses  in  data  used  to
inform these processes.
Item 22: Reproducibility - Discuss whether the model is
able  to  reproduce  the  behavior  of  other  populations  or
interventions  of  interest.    The  generalizability  of  results
(discussed in Item 23) should be emphasized along with the
generalizability  of  the  model  structure.  Some  models  are
flexible enough to describe the behavior of many populations,
while  others  are  best  suited  to  the  dynamics  in  a  single
population. Describing whether the software and programming
needed for implementing the model structure can be used to
answer  other  questions  of  interest  should  be  noted.  A
description of the generalizability of the model may encourage
collaboration with other modeling groups or authors who have
interest  in  using  the  model  structure  to  answer  alternative
questions.
Item  23:  Discussion  –  Interpret  the  modeling  analysis
within  realistic  bounds,  with  reference  to  previous
modeling studies, a discussion about the generalizability
of the modeling results, and implications for future studies
or models
The  discussion  section  of  a  modeling  paper  should
emphasize the capability of the model to represent real world
dynamics,  while  keeping  the  conclusions  grounded  upon  the
model assumptions. The generalizability of the results should
be discussed, with a particular focus on the assumptions that
allow for generalizability of the findings [12]. Future modeling
and non-modeling studies should be proposed with insight as
to how this body of work would contribute to the HIV literature
as a whole.
Item  24:  Authorship  and  Funding  -  List  sources  of
funding  and  describe  each  author’s  contribution  to  the
modeling  framework  and  conceptualization.    Listing  of
funding  sources  allows  other  modelers  to  better  understand
what  types  of  funding  sources  are  applicable  to  modeling
projects  and  grants.  Additionally,  by  listing  all  the  authors’
contributions, additional modeling teams or task forces can be
composed  based  on  capabilities  of  authors  on  previous
projects and analyses.
Search
Following the development of these reporting guidelines, we
systematically  reviewed  the  current  individual-based  HIV
transmission and prevention literature to better understand the
quality of the reporting in this field and ways in which it can be
improved.
We  searched  PubMed,  EMBASE,  BIOSYS,  and  Web  of
Science  for  modeling  papers  published  in  English  prior  to
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modified  to  the  particular  search  language  of  each  of  the
databases: an HIV infection term to capture papers related to
HIV,  transmission  and  prevention  terms  to  capture  papers
examining these particular interventions, and simulation terms
to  capture  models.  To  avoid  confusion  over  vocabulary  or
classification  of  the  modeling  papers,  a  broad  number  of
search terms were used to capture individual-based simulation
models. Details on search terms can be found in Text S1.
Following  the  removal  of  duplicates  across  databases,  all
titles and abstracts were screened for exclusion. If the title and
abstract  did  not  provide  enough  information  to  evaluate  the
inclusion  criteria  or  the  information  provided  suggested  the
model was relevant, the full text was examined and evaluated
based  on  the  inclusion  criteria.  Two  authors  (NA  and  KR)
conducted the search (Figure 1).
Inclusion and Exclusion Criteria
Papers were included in the evaluation if they described a
model that tracked individual characteristics and histories and
simulated HIV transmission between specific individuals. They
had  to  simulate  a  population  denoted  either  geographically
and/or behaviorally (e.g. men who have sex with men in the
Southern United States) and examine the effects of a particular
intervention (e.g. circumcision rollout). These inclusion criteria
allowed us to capture models that simulated HIV transmission
and prevention realistically, while eliminating models that were
exploratory or theoretical in nature.
We excluded mathematical models that did not account for
the interaction between individuals, as we believe that behavior
is an essential element of individual-based models aiming to
replicate  HIV  transmission.  Papers  that  represented  the
probability of acquiring HIV using mass action equations or the
proportion of individuals infected were not considered to model
direct  interaction.  We  also  excluded  modeling  reviews,
conference abstracts, and unpublished studies, as they did not
provide  enough  information  on  model  structure  to  warrant
evaluation.
Multiple papers utilizing the same model to answer different
questions  of  interest  were  included  and  evaluated,
acknowledging that details of model structure could be included
in previously published papers. For each paper identified in the
systematic review, the quality of reporting was evaluated based
on  the  described  recommendations.  Assessment  of  the
included models was independently undertaken by two authors
(NA and KR).
Results
Characteristics of Studies
The  search  criteria  identified  1,423  citations,  of  which  753
were  unique  records  (Figure  1).  After  initial  screening  of
abstracts and titles, 214 citations were reviewed in full text, and
32  citations  were  included  in  the  systematic  review  and
evaluation.  The  characteristics  of  the  included  studies  are
summarized in Table 2.
Individual-based microsimulation models were first published
in  the  1980’s,  though  the  oldest  model  to  fit  our  inclusion
criteria  was  published  in  1995.  The  included  analyses  were
published in a number of different journals (Table 2), ranging
from computationally focused to medical journals. About half of
them  (n=15)  were  published  in  journals  that  had  high
eigenfactor and article influence (>90th percentile respectively).
More than half of the studies (n=22) explored HIV transmission
in  heterosexual  populations,  eight  studies  analyzed  HIV
epidemics among MSM, and two studies focused on injection
drug  users  (IDUs).  Most  studies  (n=21)  were  populated  with
data  from  African  countries.  The  interventions  of  interest  in
these models varied, with many examining the presence of a
vaccine (n=6), behavioral interventions (n=13), and HIV testing
and/or  antiretroviral  treatment  (n=8)  with  several  analyses
featuring multiple interventions (n=9).
Evaluation
The number and percentage of papers that complied with the
recommended reporting guidelines are reported in Table 3 and
Figure 2. Table S1 provides the details of this evaluation for
each paper.
The  modeling  papers  almost  universally  described  the
context  in  which  the  analyses  were  performed  and  the
objectives  of  the  simulation  studies.  More  than  half  of  the
papers  (n=17)  were  not  distinguished  in  the  title  as  a
mathematical model or a simulation analysis, but all papers did
note the use of a model in the abstract. Fifty six percent of the
papers (n=18) justified the use of an individual-based model as
the necessary method to answer the question of interest. Nine
of the models included a graphical representation of the model
structure,  while  the  rest  described  the  structure  in  plain
language. Some of the papers (n=9) referred to an appendix or
a  previous  paper  for  more  detail  on  the  model  structure.
Nineteen percent (n=6) state and justify the length of the time
step  used  and  78%  of  the  papers  (n=25)  describe  how
heterogeneity  is  implemented  in  the  model  structure  or
recognize that heterogeneity was used in the individual-based
modeling  framework.  Sixty  nine  percent  (n=22)  describe  the
process  through  which  the  model  was  calibrated  to  data,
although six of the reviewed papers did not aim to accurately
represent the dynamics in a population, but rather understand
general  trends,  and  so  would  not  be  expected  to  perform  a
calibration  procedure.  Nearly  half  (n=15)  of  the  papers
summarize the impact of stochasticity on the model results and
discuss the magnitude of stochasticity in the model behavior.
Sensitivity analyses describing how the model behaved when
assumptions were altered or deleted were performed for 81%
of the papers (n=26). One paper described the validity of the
model  programming,  debugging  procedure,  and  other  details
related  to  the  implementation  and  validation  of  the
programming. Three papers discussed the issue of converting
data  to  fit  the  time  step  restrictions  in  the  model  structure.
Nearly all papers (n=31) presented the modeling results clearly;
eleven of these papers presented uncertainty estimates around
their effect estimates and predicted values. All of the papers
provided interpretations of the modeling results within realistic
bounds without overinflating the usefulness of the results.
Reporting of HIV Individual-Based Models
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We  found  that  individual-based  models  in  the  HIV
transmission  and  prevention  literature  are  able  to  answer  a
wide  range  of  questions  related  to  specific  populations  and
interventions (Table 2). The models examined how a variety of
HIV  interventions  such  as  vaccination  [17-22],  circumcision
[23,24],  condom  usage  [25-32],  reduction  in  concurrency
[25,26,29,32-34],  HIV  testing  [15,28,35-37],  anti-retroviral
treatment  [19,22,37-39],  STD  control  [25,29,30,40-45],  and
prevention of mother to child transmission [18,46,47] can affect
HIV  incidence  and  prevalence  in  a  wide  variety  of  settings
Figure 1.  Cascade of papers excluded and included in the systematic review of individual-based HIV transmission,
treatment, and prevention models in the literature.  
doi: 10.1371/journal.pone.0075624.g001
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sub-Saharan  Africa  [18,19,21,23-25,27,29,30,32-34,37-45,47].
These  analyses  were  able  to  discuss  the  effects  of
interventions  in  less  researched  and  accessible  populations
like MSM [15,17,20,22,26,28,35,36] and IDU [15,48].
We found that the reporting of results from individual-based
model analyses was very strong with respect to the basics of
public health research and other model analyses (e.g. stating
the objective, giving context from the literature, and providing
grounded  conclusions)  but  lacking  in  the  description  of
methods  particular  to  individual-based  models.  Authors  may
feel uncomfortable giving detailed descriptions of the methods
in a paper aimed at a general public health audience because
the  technical  details  may  make  the  paper  harder  to  read  or
understand. However, detailed reporting is essential to ensure
that the quality of the literature remains high and the results are
reproducible.  To  this  extent,  emphasis  on  reporting  items
related to structure (Item 5), assumptions (Item 6), calibration
(Item 13) and strengths and limitations (Item 21) will be most
Table 3. Evaluation of reporting quality in individual-based
models  in  the  HIV  transmission  and  prevention  literature
(N=32).
Item Total Number of Papers
  n (%)
1. Title and Abstract 32 (100.0)
2. Objective 30 (93.8)
3. Context 32 (100.0)
4. Model Justification 18 (56.3)
5. Structure 32 (100.0)
6. Assumptions 32 (100.0)
7. Validity of Sexual Behavior 32 (100.0)
8. Validity of Biology 31 (96.9)
9. Parameters 29 (90.6)
10. Time step 6 (18.8)
11. Heterogeneity 25 (78.1)
12. Interaction 32 (100.0)
13. Calibration 22 (68.8)
14. Sensitivity Analyses 29 (90.6)
15. Assumption Sensitivity 26 (81.3)
16. Stochastic Sensitivity 15 (46.9)
17. Internal Validity 1 (3.1)
18. Data Quality 29 (90.6)
19. Data Conversion 3 (9.4)
20. Results 31 (96.9)
21. Limitations and Strengths 28 (87.5)
22. Reproducibility 21 (65.6)
23. Discussion 32 (100.0)
24. Authorship and Funding 26 (81.3)
doi: 10.1371/journal.pone.0075624.t003
important  for  individuals  trying  to  understand  published
individual-based  models.  The  more  frequently  modeling
methods  are  included  in  public  health  analyses,  the  more
widely the methods will be accepted and valued. Additionally,
providing  detail  and  transparency  in  methods  will  encourage
collaboration  among  mathematical  modelers,  while  making
individual-based modeling more accessible to those unfamiliar
with the process.
As evidenced by the diversity of journals the models were
published in (Table 2), individual-based models are valued for
their ability to represent existing epidemics for a wide variety of
populations and regions. Just over half of the articles included
in this review noted that the analysis relied on mathematical
modeling  in  the  title,  which  suggests  that  authors  might  feel
that denoting a study as a modeling study could deter readers.
However, as this practice becomes more common, modeling
papers  will  be  read  with  the  same  clarity  and  readiness  as
other types of analyses. As more journals recognize the utility
of modeling, distinguishing model analyses from classic public
health analyses becomes more important.
Individual-based  models  are  used  widely  in  other  fields,
including ecology [49], meteorology [50], and traffic monitoring
[51], and it is encouraging to see their influence growing in the
HIV  literature.  Individual-based  modeling  is  user-friendly  and
highly  visual,  allowing  for  collaboration  and  understanding
across  multidisciplinary  teams  [52].  Strengths  of  individual-
based  models  include  their  ability  to  model  the  interaction
between  individuals  with  great  detail  and  to  reflect
heterogeneity in behavior and biology. Many authors noted the
inability  to  completely  parametrize  their  models  from  the
literature, tractably analyze models without uncertainty, and the
need for sophisticated methods of calibration to help increase
their confidence in their findings. Deterrents to individual-based
modeling in the HIV transmission literature include the lack of
biological  and  behavioral  data  in  many  populations,  which
prevents parameterization of this complex model type, as noted
in some reviewed papers [26,39].
The  creation  of  individual-based  models  is  a  complex  and
arduous process, yet standards for reporting them are relatively
non-existent. We aimed to provide guidelines to strengthen the
reporting of results in this field and an overview of individual-
based  models  examining  HIV-related  interventions.  The
existing  literature  is  broad  and  thorough;  however,  more
information  is  needed  on  the  rigor  of  calibration  and  the
rationale for the use of individual-based modeling. Future work
in this field should aim to make the literature accessible to a
general audience by using clear language that non-modelers
and  non-mathematicians  can  understand.  The  clearer  the
presentation, the more widely modeling literature will be read
and applied in the future. By collaborating with other interested
parties or modeling groups, we hope to develop a consensus
statement on the reporting of individual-based models in the
HIV treatment and prevention literature.
Reporting of HIV Individual-Based Models
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doi: 10.1371/journal.pone.0075624.g002
Reporting of HIV Individual-Based Models
PLOS ONE | www.plosone.org 10 September 2013 | Volume 8 | Issue 9 | e75624Supporting Information
Text S1.  Search terms for systematic review.
(DOCX)
Table S1.  Tabled evaluation of all eligible systematically
identified individual-based HIV transmission models based
on the reporting recommendations.
(DOCX)
Acknowledgements
The  authors  would  like  to  thank  Carol  Ann  Mita  for  her
assistance in the systematic search. The authors would also
like  to  thank  Marc  Lipsitch,  Rochelle  Walensky,  and  the
reviewers for their helpful comments on the draft.
Author Contributions
Conceived  and  designed  the  experiments:  NNA  KR  GRS.
Performed the experiments: NNA KR. Analyzed the data: NNA
KR. Wrote the manuscript: NNA.
References
1. Stover J (2000) Influence of mathematical modeling of HIV and AIDS
on policies and programs in the developing world. Sex Transm Dis 27:
572-578.  doi:10.1097/00007435-200011000-00005.  PubMed:
11099072.
2. Gilbert N (2007) Agent-based models. Sage Publications, Incorporated.
3. Law  AM,  Kelton  WD  (1991)  Simulation  modeling  and  analysis.  New
York: McGraw-Hill.
4. Marshall B, Paczkowski M, Tempalski B, Pouget E, Friedman S et al.
(2012)  Combination  interventions  for  the  prevention  of  HIV  among
injection drug users: a complex systems dynamics model. J Int AIDS
Soc 15: 108.
5. Delva W, Wilson DP, Abu-Raddad L, Gorgens M, Wilson D et al. (2012)
HIV  Treatment  as  Prevention:  Principles  of  Good  HIV  Epidemiology
Modelling for Public Health Decision-Making in All Modes of Prevention
and Evaluation. PLOS Med 9: e1001239. PubMed: 22802729.
6. Garnett  GP,  Cousens  S,  Hallett  TB,  Steketee  R,  Walker  N  (2011)
Mathematical models in the evaluation of health programmes. Lancet
378:  515-525.  doi:10.1016/S0140-6736(10)61505-X.  PubMed:
21481448.
7. Richiardi M, Leombruni R, Saam N, Sonnessa M (2006) A common
protocol for agent-based social simulation. J Artif Soc Soc 9.
8. Fone D, Hollinghurst S, Temple M, Round A, Lester N et al. (2003)
Systematic  review  of  the  use  and  value  of  computer  simulation
modelling in population health and health care delivery. J Public Health
(Oxf) 25: 325-335. doi:10.1093/pubmed/fdg075. PubMed: 14747592.
9. Rutter CM, Zaslavsky AM, Feuer EJ (2011) Dynamic Microsimulation
Models for Health Outcomes A Review. Med Decis Mak 31: 10-18. doi:
10.1177/0272989X10369005.
10. Philips  Z,  Bojke  L,  Sculpher  M,  Claxton  K,  Golder  S  (2006)  Good
practice guidelines for decision-analytic modelling in health technology
assessment:  a  review  and  consolidation  of  quality  assessment.
Pharmacoeconomics  24:  355–371.  doi:
10.2165/00019053-200624040-00006. PubMed: 16605282.
11. Grimm V, Berger U, Bastiansen F, Eliassen S, Ginot V et al. (2006) A
standard  protocol  for  describing  individual-based  and  agent-based
models.  Ecol  Modell  198:  115-126.  doi:10.1016/j.ecolmodel.
2006.04.023.
12. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC et al. (2010)
CONSORT 2010 explanation and elaboration: updated guidelines for
reporting parallel group randomised trials. BMJ 340: c869. doi:10.1136/
bmj.c869. PubMed: 20332511.
13. Van Imhoff E, Post W (1998) Microsimulation methods for population
projection.  Population:  An  English  Selection:  97-138.  PubMed:
12157954.
14. Karplus  WJ  (1977)  The  spectrum  of  mathematical  modeling  and
systems  simulation.  Math  Comput  Simulat  19:  3-10.  doi:
10.1016/0378-4754(77)90034-9.
15. Marshall BD, Paczkowski MM, Seemann L, Tempalski B, Pouget ER et
al. (2012) A complex systems approach to evaluate HIV prevention in
metropolitan  areas:  preliminary  implications  for  combination
intervention  strategies.  PLOS  ONE  7:  e44833.  doi:10.1371/
journal.pone.0044833. PubMed: 23028637.
16. Halpin B (1999) Simulation in sociology. Am Behav Sci 42: 1488-1508.
doi:10.1177/0002764299042010003.
17. Adams  AL,  Barth-Jones  DC,  Chick  SE,  Koopman  JS  (1998)
Simulations to evaluate HIV vaccine trial designs. Simul 71: 228-241.
doi:10.1177/003754979807100403.
18. Amirfar S, Hollenberg JP, Abdool Karim SS (2006) Modeling the impact
of a partially effective HIV vaccine on HIV infection and death among
women and infants in South Africa. J Acquir Immune Defic Syndr 43:
219-225.  doi:10.1097/01.qai.0000230526.79341.83.  PubMed:
16951648.
19. Gray  RH,  Li  XB,  Wawer  MJ,  Gange  SJ,  Serwadda  D  et  al.  (2003)
Stochastic  simulation  of  the  impact  of  antiretroviral  therapy  and  HIV
vaccines on HIV transmission; Rakai, Uganda. AIDS 17: 1941-1951.
doi:10.1097/00002030-200309050-00013. PubMed: 12960827.
20. Gray  RT,  Ghaus  MH,  Hoare  A,  Wilson  DP  (2011)  Expected
epidemiological impact of the introduction of a partially effective HIV
vaccine among men who have sex with men in Australia. Vaccine 29:
6125-6129. doi:10.1016/j.vaccine.2011.06.061. PubMed: 21703320.
21. Hontelez JA, Nagelkerke N, Bärnighausen T, Bakker R, Tanser F et al.
(2011)  The  potential  impact  of  RV144-like  vaccines  in  rural  South
Africa: a study using the STDSIM microsimulation model. Vaccine 29:
6100-6106. doi:10.1016/j.vaccine.2011.06.059. PubMed: 21703321.
22. Vieira  IT,  Cheng  RCH,  Harper  PR,  de  Senna  V  (2010)  Small  world
network models of the dynamics of HIV infection. Ann Oper Res 178:
173-200. doi:10.1007/s10479-009-0571-y.
23. Gray RH, Li XB, Kigozi G, Serwadda D, Nalugoda F et al. (2007) The
impact of male circumcision on HIV incidence and cost per infection
prevented: a stochastic simulation model from Rakai, Uganda. AIDS
21:  845-850.  doi:10.1097/QAD.0b013e3280187544.  PubMed:
17415039.
24. White RG, Glynn JR, Orroth KK, Freeman EE, Bakker R et al. (2008)
Male circumcision for HIV prevention in sub-Saharan Africa: who, what
and  when?  AIDS  22:  1841-1850.  doi:10.1097/QAD.
0b013e32830e0137. PubMed: 18753931.
25. Bernstein  RS,  Sokal  DC,  Seitz  ST,  Auvert  B,  Stover  J  et  al.  (1998)
Simulating  the  control  of  a  heterosexual  HIV  epidemic  in  a  severely
affected  east  African  city.  Interfaces  28:  101-126.  doi:10.1287/inte.
28.3.101.
26. Beyrer C, Baral SD, van Griensven F, Goodreau SM, Chariyalertsak S
et al. (2012) Global epidemiology of HIV infection in men who have sex
with men. Lancet 380: 367-377. doi:10.1016/S0140-6736(12)60821-6.
PubMed: 22819660.
27. Bracher M, Santow G, Watkins SC (2004) Assessing the potential of
condom  use  to  prevent  the  spread  of  HIV:  A  microsimulation  study.
Stud  Fam  Plann  35:  48-64.  doi:10.1111/j.1728-4465.2004.00005.x.
PubMed: 15067788.
28. Hallett TB, Smit C, Garnett GP, de Wolf F (2011) Estimating the risk of
HIV  transmission  from  homosexual  men  receiving  treatment  to  their
HIV-uninfected  partners.  Sex  Transm  Infect  87:  17-21.  doi:10.1136/
sextrans-2011-050102.58. PubMed: 20643658.
29. Robinson NJ, Mulder DW, Auvert B, Hayes RJ (1995) Modelling the
impact of alternative HIV intervention strategies in rural Uganda. AIDS
9:  1263-1270.  doi:10.1097/00002030-199511000-00008.  PubMed:
8561980.
30. Van  der  Ploeg  CPB,  Van  Vliet  C,  De  Vlas  SJ,  Ndinya-Achola  JO,
Fransen L et al. (1998) STDSIM: A microsimulation model for decision
support in STD control. Interfaces 28: 84-100. doi:10.1287/inte.28.3.84.
Reporting of HIV Individual-Based Models
PLOS ONE | www.plosone.org 11 September 2013 | Volume 8 | Issue 9 | e7562431. van  Vliet  C,  Meester  EI,  Korenromp  EL,  Singer  B,  Bakker  R  et  al.
(2001)  Focusing  strategies  of  condom  use  against  HIV  in  different
behavioural settings: an evaluation based on a simulation model. Bull
World Health Organ 79: 442-454. PubMed: 11417040.
32. Vissers DC, SJ DEV, Bakker R, Urassa M, Voeten HA, et al (2011) The
impact of mobility on HIV control: a modelling study. Epidemiol Infect
139:  1845-1853.  doi:10.1017/S0950268811000069.  PubMed:
21299914.
33. Enns EA, Brandeau ML (2011) Inferring model parameters in network-
based disease simulation. Health Care Manag Sci 14: 174-188. doi:
10.1007/s10729-011-9150-2. PubMed: 21373984.
34. McCreesh  N,  O’Brien  K,  Nsubuga  R,  Shafer  A  L,  Bakker  R,  et  al.
(2011) Exploring the potential impact on hiv incidence of a reduction in
concurrency in rural Uganda: A modelling study. Sex Transm Infect 87:
A37. doi:10.1136/sextrans-2011-050109.36.
35. Wilson DP, Fairley CK, Sankar D, Williams H, Keen P et al. (2011)
Replacement  of  conventional  HIV  testing  with  rapid  testing:
mathematical  modelling  to  predict  the  impact  on  further  HIV
transmission  between  men.  Sex  Transm  Infect  87:  588-593.  doi:
10.1136/sextrans-2011-050002. PubMed: 21934115.
36. Hoare  A,  Gray  RT,  Wilson  DP  (2012)  Could  implementation  of
Australia’s National Gay Men’s Syphilis Action Plan have an indirect
effect  on  the  HIV  epidemic?  Sex  Health  9:  144-151.  PubMed:
22498158.
37. Bendavid E, Brandeau ML, Wood R, Owens DK (2010) Comparative
Effectiveness  of  HIV  Testing  and  Treatment  in  Highly  Endemic
Regions. Arch Intern Med 170: 1347-1354. doi:10.1001/archinternmed.
2010.249. PubMed: 20696960.
38. Hontelez JAC, De Vlas SJ, Baltussen R, Newell ML, Bakker R et al.
(2012) The impact of antiretroviral treatment on the age composition of
the  HIV  epidemic  in  sub-Saharan  Africa.  AIDS  26:  S19-S30.  doi:
10.1097/QAD.0b013e3283558526. PubMed: 22781175.
39. Hallett TB, Baeten JM, Heffron R, Barnabas R, de Bruyn G et al. (2011)
Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant
heterosexual couples in South Africa: a modelling study. PLOS Med 8:
e1001123. PubMed: 22110407.
40. Freeman EE, White RG, Bakker R, Orroth KK, Weiss HA et al. (2009)
Population-level effect of potential HSV2 prophylactic vaccines on HIV
incidence  in  sub-Saharan  Africa.  Vaccine  27:  940-946.  doi:10.1016/
j.vaccine.2008.11.074. PubMed: 19071187.
41. Korenromp EL, Van Vliet C, Grosskurth H, Gavyole A, Van der Ploeg
CP  et  al.  (2000)  Model-based  evaluation  of  single-round  mass
treatment  of  sexually  transmitted  diseases  for  HIV  control  in  a  rural
African  population.  AIDS  14:  573-593.  doi:
10.1097/00002030-200003310-00013. PubMed: 10780720.
42. Korenromp  EL,  Bakker  R,  de  Vlas  SJ,  Gray  RH,  Wawer  MJ  et  al.
(2002)  HIV  dynamics  and  behaviour  change  as  determinants  of  the
impact of sexually transmitted disease treatment on HIV transmission in
the  context  of  the  Rakai  trial.  AIDS  16:  2209-2218.  doi:
10.1097/00002030-200211080-00014. PubMed: 12409743.
43. Korenromp EL, White RG, Orroth KK, Bakker R, Kamali A et al. (2005)
Determinants of the impact of sexually transmitted infection treatment
on  prevention  of  HIV  infection:  A  synthesis  of  evidence  from  the
Mwanza, Rakai, and Masaka intervention trials. J Infect Dis 191: S168-
S178. doi:10.1086/425274. PubMed: 15627227.
44. White  RG,  Orroth  KK,  Korenromp  EL,  Bakker  R,  Wambura  M  et  al.
(2004) Can population differences explain the contrasting results of the
Mwanza,  Rakai,  and  Masaka  HIV/sexually  transmitted  disease
intervention trials?: A modeling study. J Acquir Immune Defic Syndr 37:
1500-1513.  doi:10.1097/01.qai.0000127062.94627.31.  PubMed:
15602129.
45. Korenromp  EL,  Bakker  R,  Gray  R,  Wawer  MJ,  Serwadda  D  et  al.
(2002)  The  effect  of  HIV,  behavioural  change,  and  STD  syndromic
management on STD epidemiology in sub-Saharan Africa: Simulations
of  Uganda.  Sex  Transm  Infect  78:  i55-i63.  doi:10.1136/sti.
78.suppl_1.i55. PubMed: 12083448.
46. McCabe CJ, Goldie SJ, Fisman DN (2010) The Cost-Effectiveness of
Directly  Observed  Highly-Active  Antiretroviral  Therapy  in  the  Third
Trimester  in  HIV-Infected  Pregnant  Women.  PLOS  ONE  5:  e10154.
PubMed: 20405011.
47. Rauner  MS,  Brailsford  SC,  Flessa  S  (2005)  Use  of  discrete-event
simulation to evaluate strategies for the prevention of mother-to-child
transmission  of  HIV  in  developing  countries.  J  Oper  Res  Soc  56:
222-233. doi:10.1057/palgrave.jors.2601884.
48. Atkinson  J  (1996)  A  simulation  model  of  the  dynamics  of  HIV
transmission  in  intravenous  drug  users.  Comput  Biomed  Res  29:
338-349. doi:10.1006/cbmr.1996.0025. PubMed: 8812079.
49. Grimm V, Railsback SF (2005) Individual-based modeling and ecology.
Princeton University Press.
50. Athanasiadis  IN,  Mitkas  PA  (2004)  An  agent-based  intelligent
environmental  monitoring  system.  Manag  Environ  Qual  15:  238-249.
doi:10.1108/14777830410531216.
51. Chu L, Liu HX, Oh J-S, Recker W (2003) A calibration procedure for
microscopic traffic simulation. IEEE: 1574-1579.
52. Epstein  JM  (2009)  Modelling  to  contain  pandemics.  Nature  460:
687-687. doi:10.1038/460687a. PubMed: 19661897.
Reporting of HIV Individual-Based Models
PLOS ONE | www.plosone.org 12 September 2013 | Volume 8 | Issue 9 | e75624